Acuren Net Profit Margin 2023-2025 | TIC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Acuren net profit margin from 2023 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Acuren net profit margin from 2023 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$223.7B
Boston Scientific (BSX)	$157.9B
Stryker (SYK)	$152.8B
EssilorLuxottica (ESLOY)	$137.4B
Medtronic (MDT)	$117.5B
Lonza Group Ag (LZAGY)	$49.5B
Haleon (HLN)	$43.3B
ResMed (RMD)	$40.7B
Agilent Technologies (A)	$33.5B
GE HealthCare Technologies (GEHC)	$32.8B
Koninklijke Philips (PHG)	$25.8B
Terumo (TRUMY)	$25.1B
Insulet (PODD)	$21B
Zimmer Biomet Holdings (ZBH)	$18.5B
Baxter (BAX)	$14.4B
Smith & Nephew SNATS (SNN)	$13.5B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.8B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.7B
QuidelOrtho (QDEL)	$1.6B
Green Thumb Industries (GTBIF)	$1.3B